Abstract Atrial fibrillation affects at least 1% of the population and causes marked society-wide morbidity and mortality. Current management of atrial fibrillation including antithrombotic therapy and management of concomitant conditions in all patients. rate control therapy in most patients. and rhythm control therapy in patients with severe atrial fibrillation-related symptoms can ... https://www.roneverhart.com/Lycogel-Breathable-Concealer/